Type 2 diabetes is not “too much sugar,” but failed compensation. If you’ve ever been told that type 2 diabetes is simply “high blood sugar,” you’ve been given only the surface of the story. Blood glucose is the visible part. The real drama is happening inside your pancreas, in tiny clusters of cells called the islets of Langerhans. Within those islets live β-cells, the only cells in your body that make insulin. For years, sometimes decades, those β-cells work overtime to keep your blood glucose normal in the face of rising insulin resistance. They compensate. They adapt. They strain. And eventually, in many people, they fail. Type 2 diabetes is not just a story of excess sugar. It is the story of compensation that could not be sustained. Let’s walk through that process carefully, step by step, from early insulin resistance to β-cell failure. Blausen.com staff (2014). "Medical gallery of Blausen Medical 2014". WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.010. ISSN 200...
Introduction For decades, diabetes has been primarily viewed as a blood sugar issue. Everything focuses on the numbers: fasting glucose, post-meal glucose, and HbA1c. These metrics are certainly useful, but they only show what’s easiest to measure, not what truly drives the disease. In reality, diabetes, especially type 2 diabetes, is a systemic metabolic disorder that affects multiple organs. It involves disrupted glucose management, altered fat metabolism, ongoing low-grade inflammation, hormonal imbalance, problems with blood vessel function, immune system issues, and gradual organ damage. Long before blood glucose reaches diagnostic levels, these changes are already happening, quietly altering the body’s functioning in nearly every tissue. This is significant because diabetes doesn’t just appear at diagnosis. What lab tests reveal is the later stage of a much longer metabolic process. This article presents diabetes not as a simple state of high blood sugar but as a complete metabo...